Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed4
Recruiting1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT03386487Phase 2Completed
Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD)
Cannabis Use Disorder
PrincipalinvestigatorStart date: 2019-01-14
NCT01618656Phase 2Completed
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
Cannabis Dependence
PrincipalinvestigatorStart date: 2012-09-12
NCT01730781Recruiting
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Cannabis DependenceFamily History of AlcoholismHealthy Control+4 more
Principalinvestigator
NCT01911676Phase 2Completed
Translational Neuroscience Optimization of GlyT1 Inhibitor
Cognitive Impairments Associated With Schizophrenia
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT03386487Phase 2PrincipalInvestigator

Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD)

Cannabis Use Disorder
Completed
NCT01618656Phase 2PrincipalInvestigator

Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal

Cannabis Dependence
Completed
NCT01730781PrincipalInvestigator

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Cannabis DependenceFamily History of AlcoholismHealthy Control+4 more
Recruiting
NCT01911676Phase 2PrincipalInvestigator

Translational Neuroscience Optimization of GlyT1 Inhibitor

Cognitive Impairments Associated With Schizophrenia
Completed
NCT02576912Phase 1PrincipalInvestigator

Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone

Healthy
Completed

All 5 trials loaded